Our CEO, Sho Okiyama, our CTO, Atsushi Fukuda, and our head of HW, Takashi Yasumi, were interviewed by NICHIIKO Journal.

Aillis appoints Toshihiko Hiura, former chairman of Bain & Company Japan, as an outside director.

The verification experiment that Aillis, Yamanashi Prefecture, and Yamanashi Prefectural Central Hospital are collaborating on, was introduced on the website of Yamanashi Prefecture. Through the verification at Yamanashi Prefectural Central Hospital, we will develop nodoca into a medical device that can further contribute to society.

Aillis has been adopted for Yamanashi Prefecture’s social demonstration project ‘Phase 3 TRY!YAMANASHI! Demonstration Support Project’ and will start the nodoca demonstration experiment at Yamanashi Prefectural Central Hospital with the support of Yamanashi Prefecture.

Hiroshi Yoshihara, an AI engineer, won a Gold medal at Kaggle, an AI competition platform run by Google.

A research paper on Aillis's AI medical device "nodoca" was published in the medical journal "Journal of Medical Internet Research".

Aillis appeared in ASCII STARTUP.

Aillis appeared in DIGITALIST.

Aillis appeared in ANRITSU CORPORATION.

Our CEO, Sho Okiyama, gave a lecture at Japan MOT Society.

Aillis appeared in Nikkei Shimbun.

Aillis appeared in Ledge.ai.

Aillis appeared in ISID.

General sales of "nodoca", Japan's first AI new medical device, will begin on December 23, 2022 (Friday).

Our CEO, Sho Okiyama, gave a lecture at The 6th Symposium on Medical Device Development.

The article authored by Our executive officer, Daichi Tanaka, and Shodai Shiota was published in Journal of Health Insurance & Medical Practice titled "Government Push for Medical AI".

Aillis appeared in Nikkei Medical.

Our CEO, Sho Okiyama, gave a presentation at Healthtech/SUM 2022.

Our CEO, Sho Okiyama, gave a lecture at the 3rd annual meeting of Japanese Society of Artificial Intelligence in Ophthalmology.

An interview with our CEO, Sho Okiyama, was aired on TBS "Marutto! Saturday".